Dr Andrew Furness is Consultant Medical Oncologist based at the Royal Marsden Hospital. He treats patients with cancers of the skin and kidney and leads clinical research in solid tumour cellular therapy in a pan tumour manner. He is a Team Leader and Clinical Lead of the Centre for Translational Immunotherapy at the Institute of Cancer Research, where his research interests lie in translational immunology and cell-based immunotherapy. He leads the Solid Tumour Cellular Therapy subgroup of the British Society of Bone Marrow Transplantation and Cellular Therapy, acts as faculty member of the European Society for Medical Oncology Tumour Immunology and Immunotherapy and Investigational Immunotherapy groups. He is motivated to expand the reach of immunotherapy to a greater fraction of patients with solid tumours and hopes to achieve this through cell-based approaches and a better understanding of the biology underlying response and resistance to existing approaches.